ALLI-TRIPLE 50/.25/50/50 MG 6 TAB DEPOFARMA S A PRINCIPIO ACTIVO: LORATADINA MONTELUKAST

Description

PRINCIPIO ACTIVO: LORATADINA MONTELUKAST

DOSIS: 30X5 M

No administrar en presencia de infección activa grave

Contenido por sobre: 3150 mg

Belimumab 120 mg

ALLI-TRIPLE 50/.25/50/50 MG 6 TAB DEPOFARMA S A PRINCIPIO ACTIVO: LORATADINA MONTELUKASTPRINCIPIO ACTIVO: DICLOFEN,CIANOCOBALAM,PIRIDOXINA,TIAMINA

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy